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Abstract
Background: Parkinson's disease (PD) is the second most common chronic neurological disorder
of the elderly. Despite the fact that a comprehensive review of general health care in the United
States showed that the quality of care delivered to patients usually falls below professional
standards, there is limited data on the quality of care for patients with PD.
Methods:  Using the administrative database, the Pacific Northwest Veterans Health
Administration (VHA) Data Warehouse, a population of PD patients with encounters from 10/1/
98-12/31/04 were identified. A random sample of 350 patient charts underwent further review for
diagnostic evaluation. All patients whose records revealed a physician diagnosis of definite or
possible Idiopathic Parkinson's (IPD) disease (n = 150) were included in a medical chart review to
evaluate adherence to five evidence-based quality of care indicators.
Results: For those care indicators with good inter-rater reliability, 16.6% of care received by PD
patients was adherent for annual depression screening, 23.4% of care was adherent for annual fall
screening and, 67.3% of care was adherent for management of urinary incontinence. Patients
receiving specialty care were more likely to be adherent with fall screening than those not receiving
specialty care OR = 2.3, 95%CI = 1.2–4.2, but less likely to be adherent with management of urinary
incontinence, OR = 0.3, 95%CI = 0.1–0.8. Patients receiving care outside the VA system were more
likely to be adherent with depression screening OR = 2.4, 95%CI = >1.0–5.5 and fall screening OR
= 2.2, 95%CI = 1.1–4.4.
Conclusion: We found very low rates of adherence for annual screening for depression and falls
for PD patients but reasonable adherence rates for management of urinary incontinence.
Interestingly, receiving concurrent specialty care did not necessarily result in higher adherence for
all care indicators suggesting some coordination and role responsibility confusion. The increased
adherence in PD patients receiving care outside the VA system suggests that patients with outside
care may demand better care within the VA system.
Background
Parkinson's disease (PD), after Alzheimer's dementia, is
the second most common chronic neurological disorder
of the elderly [1]. Despite the fact that a comprehensive
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review of general health care in the United States showed
that the quality of care delivered to patients usually falls
below professional standards [2], there is limited data on
the quality of care for patients with PD. One study showed
that less than one-third of patients initially diagnosed
with PD by a non-neurologist were eventually referred to
a neurologist for care [3], even though non-neurologists
may not have adequate knowledge to manage PD patients
[4].
Nevertheless, there have been no large-scale efforts to
comprehensively measure the quality of PD care because,
in part, because the necessary tools to perform an explicit
review of the processes of PD care have not been devel-
oped. The most widely used method to measure quality is
based on an explicit review of the processes of medical
care [5], which is frequently conducted by structured
abstraction of information from the medical record or
through patient interviews. Recently, a health services
research team, consisting of members of the National VA
Parkinson's Disease Research, Education and Clinic
Center (PADRECC), developed a set of evidence-based
indicators that could be used to evaluate and measure the
quality of care received by patients with Parkinson's dis-
ease, as measured by medical care process [6]. These indi-
cators describe the care recommended through expert
consensus of the scientific evidence in several domains of
care, including preventative, primary and specialty care.
The goal of this research study is to evaluate how closely a
select number of care areas, i.e. depression and fall screen-
ing, as well as management of orthostatic hypotension,
urinary incontinence and hallucinations in Parkinson's
disease patients are consistent with the care recom-
mended by the scientific evidence supporting these rec-
ommended practices.
Methods
Identifying patient sample/sample size calculation
Using the administrative database, the Pacific Northwest
Veterans Health Administration (VHA) Data Warehouse,
the population of patients in the Pacific Northwest
(Alaska, Washington, Oregon, Idaho) with encounters
from 10/1/98-12/31/04 with parkinsonism ICD-9 CM
codes 332.0, 333.0, 332.1, 333.90 (n = 3863) or a
dopaminergic medication (n = 5864), i.e. carbidopa/levo-
dopa or a dopamine agonist were identified. Assuming a
significance level of 0.05, and power of 80%, we esti-
mated we would need approximately 200 patients with
PD to have enough power to detect a 5% difference in
adherence between specialty and non-specialty visits to
annual care indicators with rates of 10% and above.
Because approximately 60% of patients identified by
these four ICD-9 codes for parkinsonism and/or a
dopaminergic medication had a physician diagnosis for
idiopathic parkinsonism upon chart review in a previous
study [7], a random sample of 350 patient charts under-
went further review for diagnostic evaluation. The two ear-
liest and two latest movement disorder, neurology, or
primary care notes within this time period were reviewed
for diagnostic confirmation. All patients (n = 150) whose
records revealed a physician diagnosis of definite or pos-
sible Idiopathic Parkinson's disease were included for
review of the quality of care indicators. Information was
also collected on diagnostic criteria for parkinsonism such
as rigidity, tremor, bradykinesia, and postural instability.
Supportive clinical criteria for IPD was collected, e.g. uni-
lateral onset, excellent response to levodopa, progressive
nature, persistent asymmetry, levodopa induced motor
fluctuations, and response to levodopa greater than five
years. Non-supportive criteria were also collected such as
bilateral onset, non-response to levodopa, history of
schizophrenia, strokes or head injury, early dementia, and
cerebellar findings.
Selection of care indicators
Five care indicators were chosen for use in this analysis
representing a range of preventative, primary and spe-
cialty care from the original 16 PD-specific "Evidence-
Based Guide to Key Care Processes in Parkinson's Disease
Management" indicators that met expert consensus crite-
ria for needing room for improvement and having high
impact on patient outcomes if improved[6]. These indica-
tors were chosen because they represent a broad range of
preventive, primary and specialty care areas: annual
screening for depression, annual screening for falls, man-
agement of urinary incontinence, management of orthos-
tatic hypotension and management of hallucinations. The
list of indicators including their eligibility and adherence
criteria is shown in Table 1.
Development of medical chart abstraction instrument
Each week, members of the research team (KS, EC, EG,
BGV) tested the ability of the instrument to accurately
extract information about the care indicators. The research
team met weekly to discuss the instrument performance
and to make adjustments. The instrument development
team also included Health Services Researchers at the VA
Greater Los Angeles Healthcare System who were involved
in the development of the original indicators. Using
Microsoft Access software, interface forms were created.
The instrument was constructed to have multiple linked
Access interface forms that seamlessly guide the medical
chart reviewer through questions about the presence or
absence of recorded data within each note on a note-by-
note basis. Reviewers (EG, JA) are asked to record dates
and clinics for all entered data. The layout of the instru-
ment is such that it asks for the presence or absence of data
elements in each note. Therefore, time period or condi-
tional requirements for indicator eligibility and adherenceBMC Neurology 2006, 6:26 http://www.biomedcentral.com/1471-2377/6/26
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are calculated by post hoc data analysis, rather than asking
reviewers to assess eligibility or adherence across different
notes and time periods. This methodology is objective
and therefore conforms more closely to explicit judgment.
This instrument was developed and tested during a six
month period by the research team in collaboration with
researchers at the VA Greater Los Angeles Healthcare Sys-
tem. The instrument was pilot tested on twenty-five
patient records to assess face validity and reliability prior
to use.
Data collection
Patient records from all sites in the Pacific Northwest VHA
were accessed and reviewed using the Computerized
Patient Record System (CPRS). A trained medical chart
reviewer with a master's degree in Public Health reviewed
all patient records (EG). A second trained medical chart
reviewer (JA) blinded to the results of the first reviewer
evaluated 7% (n = 23) charts to assess inter-rater reliabil-
ity for diagnostic accuracy and for presence of care criteria
for indicators. The trained medical reviewers extracted
data using an Access-based interactive instrument. All
patient encounters are uploaded into the instrument from
the Pacific Northwest VHA Data Warehouse database and
listed on a reference table in the instrument to assist the
medical chart reviewer in negotiating the encounters and
ensure that notes are properly included or excluded based
on the criteria. All outpatient clinic visit notes written by
physicians, nurse practitioners, physician assistants, psy-
chologists or therapists for primary care, general medi-
cine, geriatrics, neurology, neurology specialties,
emergency visits, physical, kinesiotherapy and occupa-
tional therapy, rehabilitation, and mental health were
reviewed. In addition, all telephone contacts for the above
providers were reviewed. No inpatient records were
reviewed. However extended care and residential care
notes were reviewed since this is the only mechanism by
which some patients are seen by a healthcare provider in
the Pacific Northwest VHA. Notation of non-VA care was
also recorded. The study was approved by the Portland VA
Medical Center Internal Review Board and Research &
Development Committee, VA #02-3404.
Analysis
Differences in patient characteristics and demographics
were compared using chi-square and t-test analyses for
patients whose diagnosis qualified them for further indi-
cator review and for patients whose diagnosis did not
qualify them for further review.
Inter-rater reliability was evaluated using the Kappa co-
efficient for the qualifying diagnoses and the presence of
the care criteria for each indicator for each patient. Adher-
ence and eligibility rates and bi-variate analyses are
reported in patient-years. For each patient-year, there was
a designation of eligibility (yes/no) for the indicator and
whether the patient received care that adhered to the qual-
ity indicator (yes/no) for each encounter. To calculate eli-
gibility and adherence in patient years, any encounter
from the first visit to a period within 364 days is consid-
ered the patient's first year, any visits within 365–729 days
is the second year, etc. A patient-year is defined as having
specialty care if any encounter during that period was for
specialty care: geriatrics, neurology or movement disor-
ders visit. A patient-year is defined as having non-VA care
if any encounter during that period noted non-VA care.
Any encounter during the year that qualifies the patient to
be eligible or adherent results in that patient-year being
Table 1: Adherence and eligibility criteria and level of evidence for the Parkinson's disease quality of care indicators
Defined eligibility = denominator Defined adherence = numerator Level of 
evidence*
Domain
Urinary incontinence 
management
PD patient with new urinary 
incontinence or worsening urinary 
incontinence
Documenting that discussed with 
patient and offered patient several 
treatment options
A1 Management of non motor 
complications
Annual depression 
screening
Each year in cohort for patients 
with PD
Screening for depression with at least 
note of the presence or absence
A1 Management of dementia, 
depression, psychosis
Annual fall screening Each year in cohort for patients 
with PD
Medical record documents patient 
asked about falls at least once a year
Indirect Management of motor 
complications
Orthostatic 
hypotension 
management
Patient with symptomatic 
orthostatic hypotension not 
responsive to behavioral 
modification
Prescribing midodrine or 
fludrocortisone
A1/C1 Management of non motor 
complications
Hallucination 
management
Patient with PD having persistent 
hallucinations or delirium not 
improved by a discontinuation or 
reduction of PD medications
Prescribing quetiapine or clozapine 
rather than prescribing 
contraindicated neuroleptic or no 
anti-psychotic at all
A1 Management of dementia, 
depression, psychosis
*A1 = randomized clinical trial, B1 = prospective observational study, C1 = cross-sectional or historical observational study shows benefitBMC Neurology 2006, 6:26 http://www.biomedcentral.com/1471-2377/6/26
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assigned an adherent or eligible patient-year. Bi-variate
analyses using chi square and Fisher's exact test were used
to evaluate the association between adherence to indica-
tors of care and the presence of specialty care during that
year and the presence of non-VA care.
The average number of encounters per eligibility period
was also calculated for patients who received specialty
care and for patients who did not receive any specialty
care.
Results
Characteristics of patients with and without a qualifying 
diagnosis for further PD care indicator abstraction
317/350 patients had adequate medical records allowing
for determination of a patient diagnosis. Of the 317
patient records, 150 had either idiopathic Parkinson's dis-
ease or possible idiopathic Parkinson's disease. Not sur-
prisingly, patients deemed to have PD differed from those
who were not deemed to have PD on most demographic
and clinical characteristics evaluated. (Table 2.) The
Kappa co-efficient for inter-rater reliability for a qualifying
diagnosis was 1.0, with 95% CI: 0.6–1.4.
Patient encounters
44/150 or 29.3% of PD patients had care outside the VA
mentioned in their records. 79/150 or 52.7% of PD
patients had seen a specialist at some point in their care.
The average number of encounters per eligibility period
for fall and depression screening (per patient-year) was
5.3 for those receiving specialty care and 2.7 for those not
receiving specialty care. (p < .001) The majority of visits
for PD patients was for primary care and internal medi-
cine. (Table 3.)
Rates of adherence for quality indicators
For annual depression screening, 16.6% of care received
by PD patients was adherent. 23.4% of care was adherent
for annual fall screening. 29.7% of care was adherent for
management of orthostatic hypotension, 67.3% was
adherent for management of urinary incontinence, and
60% was adherent for management of hallucinations.
Kappa coefficients for inter-rater reliability exceeded 0.7
for recording the presence of depression, falls and urinary
incontinence. The Kappa coefficient for the presence of
orthostatic hypotension and hallucinations could not be
calculated due to not enough instances of an assessment
recorded as positive to reliably report management.
Patients receiving specialty care in a given year were more
likely to be adherent with fall screening than those not
receiving specialty care OR = 2.3, 95%CI = 1.2–4.2, but
less likely to be adherent with management of urinary
incontinence, OR = 0.3, 95%CI = 0.1–0.8. (Figure 1.)
Patients receiving care outside the VA system were more
likely to be adherent with depression screening OR = 2.4,
95%CI = >1.0–5.5 and fall screening OR = 2.2, 95%CI =
1.1–4.4. (Figure 2.)
Discussion
Our rates of adherence for depression screening were
remarkably low as reported in the provider's encounter
note and the indicator demonstrated good inter-rater reli-
ability. In the Pacific Northwest VHA, the majority of
patients are screened for depression by a primary care
intake nurse but the results are not reported in encounter
notes. Our study only extracted provider encounter notes.
The provider must be aware of the screen results and feel
the results are clinically important to make a notation in
their encounter note. Thirty-five percent of the PD
patients in our sample had been given an ICD-9 CM code
for depression and the prevalence of depression in other
PD patient populations has been shown to be 40–50%
[8,9]. Therefore, it is likely that providers are either 1) not
determining the screening results of their patients or 2)
not recording the presence or absence of depression in
their PD patients' management. Although encounter visits
doubled after patients began seeing specialists, the rate of
annual screening for depression did not improve. Given
that depression is so prevalent in PD patients and that
depression and disability are associated [10], our findings
strongly suggest that providers are neither recording the
presence of depression nor considering depression an
important co-morbidity in PD patients. Interestingly,
patients with non-VA care had nearly double the rate of
depression screening recorded in the encounter note com-
pared to those without outside care. Since we did not
review outside notes, this increased rate reflects VA pro-
viders noting the presence or absence of depression in
their own evaluation and management. The higher rate of
depression screening in patients with outside VA care
could be for several reasons. Patients with outside care
may be more pro-active and demand their providers be
more thorough in their management. VA providers may
be also more thorough because they worry that patients
with outside care may not be getting as good as care as
patients without outside care.
Adherence to recommended fall screening was also very
low and the indicator demonstrated good inter-rater reli-
ability. The most common complications of patients with
PD are axial features such as gait impairment and falls
[11]. In a prospective study of PD patients with average
duration of illness of three years, falls occurred in over
two-thirds of PD patients annually with half of the PD
patients experiencing more than one fall [12]. For 100 PD
patients followed over two months, 20 hospitalizations
occurred for falls of which three-quarters were for frac-
tures and the rest for lacerations [13]. Finally, falls are a
leading cause of nursing home admissions in a general
elderly population [14]. Given the prevalence of falls andBMC Neurology 2006, 6:26 http://www.biomedcentral.com/1471-2377/6/26
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its association with poor patient outcomes, the low adher-
ence rates for screening are concerning.
Patients who received care outside the VA had higher
screening rates for falls and this may be for the same rea-
sons as the higher depression screening rates seen in
patients receiving outside care. However unlike depres-
sion screening, patients with specialty care had higher
rates of adherence for annual fall screening. There are two
possible reasons why patients who are seeing specialists
have a higher rate of adherence to annual fall screening. It
may be that patients that see specialists are more likely to
have fallen and therefore report falls to their providers.
Alternatively, it may be that specialists are more aware of
Table 2: Demographics and characteristics of the patient records that were, and were not, deemed to have possible or definite 
idiopathic Parkinson's disease
Deemed to have IPD N = 150 Deemed not to have IPD N = 167 p-value
Date of birth, mean 1929 1935 <0.0001
Age at death, mean, n 75.8, n = 10 79.6, n = 16 0.30
Period of Service, no. (%) 0.01
WWII (50.3) (30.4)
Vietnam (22.6) (35.6)
Other (27.0) (34.0)
Percent service connected, mean 57.3 62.7 <0.0001
Gender, no. (%) 0.09
Male (96.9) (92.7)
ICD-9 CM codes, no. (%)
332.0 (76.1) (30.4) <.0001
332.1 (14.4) (0.6) 0.006
333.0 (8.8) (4.7) 0.12
333.90 (5.0) (10.5) 0.06
311 (depression) (35.2) (37.1) 0.71
Diagnoses
IPD 113 -
Possible IPD 37 -
Medication-induced 
parkinsonism
17 -
Parkinsonism 10 -
Non-parkinsonism movement 
disorder
93 -
Other neurological disorder 47 -
Clinical characteristics
Postural instability 26 (17.3) 4 (2.4) <0.0001
Bradykinesia 51 (34.0) 5 (3.0) <0.0001
Rigidity 46 (30.7) 8 (4.8) <0.0001
Resting tremor 61 (40.7) 11 (6.6) <0.0001
Gait difficulty 47 (31.3) 6 (3.6) <0.0001
Table 3: Type of encounter visits for patients deemed to have idiopathic Parkinson's disease
Clinic Number of visits Percent of all visits
Primary Care/Medicine 384 46.8
Neurology 240 29.2
Mental Health/Psychiatry 78 9.5
PADRECC* 52 6.3
Geriatrics 20 2.4
Physical therapy 27 3.3
Kinesiotherapy 16 2.0
Occupational therapy 4 0.5
Total 821 100
*Parkinson's Disease Research Education and Clinical CenterBMC Neurology 2006, 6:26 http://www.biomedcentral.com/1471-2377/6/26
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falls as a complication of PD and are more likely to ask
patients about falls. Regardless, considering that even
with specialty care, adherence rates were less than a third,
interventions specifically targeting fall screening should
be of prime importance.
Discussion of treatment options for urinary incontinence
had the highest adherence rates of any of the indicators
and the indicator also demonstrated good reliability.
Greater than half of patients who had symptoms of incon-
tinence received appropriate management advice. Surpris-
ingly, patients who received specialty care were much less
likely to receive appropriate care. The high adherence rate
among non-specialty providers may reflect the fact that
urinary incontinence occurs with some frequency in
patients without PD. Nevertheless, urinary symptoms
occur in 40% of PD patients [11]. Our finding that
patients who received specialty care in addition to pri-
mary care had lower rates of adherence suggests that there
may be a negative outcome from the coordination of care
between specialists and generalists. Both provider groups
may believe that the other provider group is responsible
for managing urinary incontinence.
Inter-rater reliability for the management of hallucina-
tions could not be calculated due to not enough instances
of an assessment recorded as positive to reliably report
management. Of those patients who had hallucinations,
greater than half were managed appropriately. The pres-
ence of hallucinations has been shown to be a stronger
predictor of nursing home placement for patients with PD
compared to motor and cognitive impairment [15,16]. In
particular, the presence of hallucinations early in the treat-
ment of parkinsonism is associated with increased proba-
bility of nursing home placement [17]. The low number
of eligibility periods we found in this study suggests that
providers may not be asking or recording the presence of
hallucinations. Because of the importance of manage-
ment of hallucinations for patient outcomes, future
research may want to first focus on accurate screening for
hallucinations.
Inter-rater reliability for the management of orthostatic
hypotension also could not be calculated due to not
enough instances of an assessment recorded as positive to
reliably report management. Adherence was less than a
third and none of the predictor variables influenced
adherence.
In addition to evaluating rates of adherence to several evi-
dence-based care indicators in patients with PD, this study
had two other important findings. Our study confirmed
that medical chart review is necessary to identify cases of
PD. Less than half of the patient medical charts identified
with administrative data had confirmed or probable PD
on medical chart review. The author has shown previously
that administrative data is inaccurate in identifying cases
of PD for quality of care assessments [7]. This study also
found that only half of the veterans with PD were seen by
specialists. This is consistent with other studies of non-VA
PD populations in both the U.S. and Canada that have
shown PD patients have limited access to specialty care
[3,18].
Our study is limited in that two of the care indicators had
too few instances of an assessment recorded as positive to
Adherence to care indicators by VA care only vs. VA and  non-VA care Figure 2
Adherence to care indicators by VA care only vs. VA 
and non-VA care. *Chi square significant at the p < 0.05 
level
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reliably report management and therefore caution must
be taken in interpreting the results of those indicators. For
the rest of our indicators and for qualifying diagnoses,
inter-rater reliability was high. While blinded, both our
raters were involved in the development of the abstraction
instrument and therefore their familiarity with the instru-
ment may have resulted in higher rates of reliability than
might otherwise be found in raters.
Another limitation of our study is that our rates of adher-
ence to PD care indicators may not be generalizable out-
side the Pacific Northwest VA system. Rates reported by
the VA Greater Los Angeles Healthcare system using a sim-
ilar instrument were higher than those reported by us:
annual screening rates for depression of 67% and annual
screening rates for falls of 52% [19]. The differences in
rates between the two VHA systems may be a result of the
higher prevalence of PD specialty care at the VA Greater
Los Angeles Healthcare system or the fact that care was
evaluated in the year 2003 at West Los Angeles VA whereas
care was evaluated from 1998–2004 for the Pacific North-
west VA. Regardless, these findings suggest a large amount
of geographic variability of care delivered to PD patients
and require further evaluation.
The findings of this study suggest that physician profes-
sional societies or Parkinson's disease organizations
might consider promoting screening for PD patients to
improve adherence to care indicators. These organizations
could make available a standardized set of questions
about recent falls, hallucinations, symptoms of orthos-
tatic hypotension and a self-administered depression
scale that PD patients could complete prior to their clinic
visits.
Conclusion
We found very low rates of adherence to evidence-based
care indicators for annual screening for depression and
falls for PD patients but some reasonable adherence rates
to indicators for management of urinary incontinence.
Because reliability estimates could not be obtained,
adherence rates to indicators for management of halluci-
nations and orthostatic hypotension should be inter-
preted with caution, but the low rates of eligibility
suggests initial screening for these disorders may be war-
ranted. Interestingly, receiving concurrent specialty care
did not necessarily result in higher adherence for all care
indicators suggesting some coordination and role respon-
sibility confusion. The increased adherence in PD patients
receiving care outside the VA system suggests that patients
with outside care are treated differently by VA providers.
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